| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $411.1M | +13.7% | +15.9% |
| Cost of Revenue | $68.8M | +6.9% | +7.9% |
| Gross Profit | $342.3M | +15.1% | +17.7% |
| R&D Expense | $96.9M | -1.5% | -0.1% |
| SG&A Expense | $53.2M | +0.5% | +6.2% |
| Operating Income | $13.1M | +164.8% | +130.1% |
| Pre-tax Income | $24.6M | +639.2% | +196.4% |
| Income Tax | -$174.2M | — | -1073.9% |
| Net Income | $198.8M | — | +1966.2% |
| EPS (Basic) | $0.37 | — | +1950.0% |
| EPS (Diluted) | $0.37 | — | +1950.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $743.7M | +18.3% | -3.9% |
| Short-term Investments | $654.5M | -20.1% | -17.7% |
| Accounts Receivable | $366.8M | +35.9% | +9.1% |
| Current Assets | $2.09B | +3.1% | -3.8% |
| Total Assets | $2.90B | +11.7% | +8.7% |
| Current Liabilities | $788.7M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $188.9M | — | — |
| Capital Expenditures | $16.0M | — | — |
| Investing Cash Flow | $20.2M | — | — |
| Financing Cash Flow | -$358.0M | — | — |
| Free Cash Flow | $172.9M | — | — |
| +13.4% |
| Total Liabilities | $971.4M | +4.8% | +4.3% |
| Stockholders' Equity | $1.92B | +15.5% | +11.1% |